Sazdova I, Keremidarska-Markova M, Dimitrova D, Mitrokhin V, Kamkin A, Hadzi-Petrushev N
Cancers (Basel). 2023; 15(22).
PMID: 38001739
PMC: 10670065.
DOI: 10.3390/cancers15225478.
Jamil S, Hamizah Ali A, Feroz S, Lam S, Kartini Agustar H, Abd Razak M
Pharmaceuticals (Basel). 2023; 16(4).
PMID: 37111366
PMC: 10146798.
DOI: 10.3390/ph16040609.
Hussein H, Khaphi F
Appl Biochem Biotechnol. 2023; 195(8):5019-5033.
PMID: 37032374
DOI: 10.1007/s12010-023-04454-5.
Gor R, Ramachandran I, Ramalingam S
Curr Top Med Chem. 2022; 22(31):2589-2597.
PMID: 36380414
DOI: 10.2174/1567205020666221114112814.
Nocito M, De Luca A, Prestia F, Avena P, Padula D, Zavaglia L
Biomedicines. 2021; 9(10).
PMID: 34680593
PMC: 8533288.
DOI: 10.3390/biomedicines9101476.
Molecular Mechanisms of Antiproliferative and Apoptosis Activity by 1,5-Bis(4-Hydroxy-3-Methoxyphenyl)1,4-Pentadiene-3-one (MS13) on Human Non-Small Cell Lung Cancer Cells.
Wan Mohd Tajuddin W, Abas F, Othman I, Naidu R
Int J Mol Sci. 2021; 22(14).
PMID: 34299042
PMC: 8307969.
DOI: 10.3390/ijms22147424.
A New Pentafluorothio-Substituted Curcuminoid with Superior Antitumor Activity.
Linder B, Kohler L, Reisbeck L, Menger D, Subramaniam D, Herold-Mende C
Biomolecules. 2021; 11(7).
PMID: 34202286
PMC: 8301868.
DOI: 10.3390/biom11070947.
Perspectives for synthetic curcumins in chemoprevention and treatment of cancer: An update with promising analogues.
Adeluola A, Zulfiker A, Brazeau D, Amin A
Eur J Pharmacol. 2021; 906:174266.
PMID: 34146588
PMC: 8286352.
DOI: 10.1016/j.ejphar.2021.174266.
The Nrf2/PGC1 Pathway Regulates Antioxidant and Proteasomal Activity to Alter Cisplatin Sensitivity in Ovarian Cancer.
Deng X, Lin N, Fu J, Xu L, Luo H, Jin Y
Oxid Med Cell Longev. 2020; 2020:4830418.
PMID: 33294122
PMC: 7714579.
DOI: 10.1155/2020/4830418.
In-Vitro and In-Silico Evaluations of Heterocyclic-Containing Diarylpentanoids as Bcl-2 Inhibitors Against LoVo Colorectal Cancer Cells.
Leong S, Chia S, Abas F, Yusoff K
Molecules. 2020; 25(17).
PMID: 32858795
PMC: 7504466.
DOI: 10.3390/molecules25173877.
The Curcumin Analogue, MS13 (1,5-Bis(4-hydroxy-3- methoxyphenyl)-1,4-pentadiene-3-one), Inhibits Cell Proliferation and Induces Apoptosis in Primary and Metastatic Human Colon Cancer Cells.
Ismail N, Othman I, Abas F, Lajis N, Naidu R
Molecules. 2020; 25(17).
PMID: 32825505
PMC: 7504349.
DOI: 10.3390/molecules25173798.
The Curcumin Analogue, EF-24, Triggers p38 MAPK-Mediated Apoptotic Cell Death via Inducing PP2A-Modulated ERK Deactivation in Human Acute Myeloid Leukemia Cells.
Hsiao P, Chang J, Lee W, Ku C, Tsai M, Yang S
Cancers (Basel). 2020; 12(8).
PMID: 32759757
PMC: 7464750.
DOI: 10.3390/cancers12082163.
Anti-Cancer and Ototoxicity Characteristics of the Curcuminoids, CLEFMA and EF24, in Combination with Cisplatin.
Monroe J, Hodzic D, Millay M, Patty B, Smith M
Molecules. 2019; 24(21).
PMID: 31671767
PMC: 6864451.
DOI: 10.3390/molecules24213889.
Molecular Pathways Modulated by Curcumin Analogue, Diarylpentanoids in Cancer.
Paulraj F, Abas F, Lajis N, Othman I, Naidu R
Biomolecules. 2019; 9(7).
PMID: 31295798
PMC: 6681237.
DOI: 10.3390/biom9070270.
Biological Effects of EF24, a Curcumin Derivative, Alone or Combined with Mitotane in Adrenocortical Tumor Cell Lines.
Bertazza L, Barollo S, Mari M, Faccio I, Zorzan M, Redaelli M
Molecules. 2019; 24(12).
PMID: 31212829
PMC: 6630722.
DOI: 10.3390/molecules24122202.
Bioactivities of EF24, a Novel Curcumin Analog: A Review.
He Y, Li W, Hu G, Sun H, Kong Q
Front Oncol. 2019; 8:614.
PMID: 30619754
PMC: 6297553.
DOI: 10.3389/fonc.2018.00614.
Curcumin attenuates proangiogenic and proinflammatory factors in human eutopic endometrial stromal cells through the NF-κB signaling pathway.
Chowdhury I, Banerjee S, Driss A, Xu W, Mehrabi S, Nezhat C
J Cell Physiol. 2018; 234(5):6298-6312.
PMID: 30259980
PMC: 6344303.
DOI: 10.1002/jcp.27360.
The curcuminoid, EF-24, reduces cisplatin-mediated reactive oxygen species in zebrafish inner ear auditory and vestibular tissues.
Monroe J, Millay M, Patty B, Smith M
J Clin Neurosci. 2018; 57:152-156.
PMID: 30243600
PMC: 6191333.
DOI: 10.1016/j.jocn.2018.09.002.
Apoptosis Induced by the Curcumin Analogue EF-24 Is Neither Mediated by Oxidative Stress-Related Mechanisms nor Affected by Expression of Main Drug Transporters ABCB1 and ABCG2 in Human Leukemia Cells.
Skoupa N, Dolezel P, Ruzickova E, Mlejnek P
Int J Mol Sci. 2017; 18(11).
PMID: 29088066
PMC: 5713259.
DOI: 10.3390/ijms18112289.
A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapies.
Bisht S, Schlesinger M, Rupp A, Schubert R, Nolting J, Wenzel J
J Nanobiotechnology. 2016; 14(1):57.
PMID: 27401816
PMC: 4940769.
DOI: 10.1186/s12951-016-0209-6.